284 related articles for article (PubMed ID: 29465703)
21. Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.
Edelman EJ; Moore BA; Calabrese SK; Berkenblit G; Cunningham C; Patel V; Phillips K; Tetrault JM; Shah M; Fiellin DA; Blackstock O
AIDS Behav; 2017 Apr; 21(4):1025-1033. PubMed ID: 27896552
[TBL] [Abstract][Full Text] [Related]
22. Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
McKellar MS; Des Marais AC; Chen H; Choi Y; Lilly R; Ayers D; Bennett J; Kestner L; Perry B; Poley S; Corneli A; Meade CS; Sachdeva N
Harm Reduct J; 2024 Mar; 21(1):69. PubMed ID: 38532395
[TBL] [Abstract][Full Text] [Related]
23. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI
Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005
[TBL] [Abstract][Full Text] [Related]
24. Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs-Cabell County, West Virginia, 2019.
Furukawa NW; Weimer M; Willenburg KS; Kilkenny ME; Atkins AD; Paul McClung R; Hansen Z; Napier K; Handanagic S; Carnes NA; Kemp Rinderle J; Neblett-Fanfair R; Oster AM; Smith DK
Public Health Rep; 2022; 137(1):25-31. PubMed ID: 33646890
[TBL] [Abstract][Full Text] [Related]
25. Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting.
Escudero DJ; Kerr T; Wood E; Nguyen P; Lurie MN; Sued O; Marshall BD
AIDS Behav; 2015 May; 19(5):752-7. PubMed ID: 25086669
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.
Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Chaipung B; Worrajittanon D; Leethochawalit M; Chiamwongpaet S; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Curlin ME; Holtz TH; Samandari T; Choopanya K;
Lancet HIV; 2017 Feb; 4(2):e59-e66. PubMed ID: 27866873
[TBL] [Abstract][Full Text] [Related]
27. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1291-5. PubMed ID: 26606148
[TBL] [Abstract][Full Text] [Related]
28. Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida.
Jo Y; Bartholomew TS; Doblecki-Lewis S; Rodriguez A; Forrest DW; Tomita-Barber J; Oves J; Tookes HE
PLoS One; 2020; 15(4):e0231424. PubMed ID: 32298320
[TBL] [Abstract][Full Text] [Related]
29. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022.
Suprasert B; Tate M; Reagan D; Ruiz R; Gao K; McNaughton K; Miller K; Marr A; Taylor KD; Wilson EC; McFarland W
AIDS Behav; 2024 Jun; 28(6):2089-2100. PubMed ID: 38526638
[TBL] [Abstract][Full Text] [Related]
30. Factors Associated with Awareness of Pre-exposure Prophylaxis for HIV Among Persons Who Inject Drugs in Philadelphia: National HIV Behavioral Surveillance, 2015.
Roth A; Tran N; Piecara B; Welles S; Shinefeld J; Brady K
AIDS Behav; 2019 Jul; 23(7):1833-1840. PubMed ID: 30267367
[TBL] [Abstract][Full Text] [Related]
31. Impact of the Early COVID-19 Pandemic on the Number of HIV Preexposure Prophylaxis Uses and the Proportion of Preexposure Prophylaxis Users Receiving Sexually Transmitted Infection Testing Services.
Schmidt MA; Salas SB; Donald JL; Gift TL; Tao G
Sex Transm Dis; 2023 May; 50(5):304-309. PubMed ID: 36730891
[TBL] [Abstract][Full Text] [Related]
32. The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals.
Mistler CB; Curley CM; Rosen AO; El-Krab R; Wickersham JA; Copenhaver MM; Khati A; Shrestha R
J Community Health; 2021 Oct; 46(5):960-966. PubMed ID: 33770334
[TBL] [Abstract][Full Text] [Related]
33. Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs.
Picard J; Jacka B; Høj S; Laverdière É; Cox J; Roy É; Bruneau J
AIDS Behav; 2020 Aug; 24(8):2400-2408. PubMed ID: 31997057
[TBL] [Abstract][Full Text] [Related]
34. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention.
Walters SM; Reilly KH; Neaigus A; Braunstein S
Harm Reduct J; 2017 Jun; 14(1):40. PubMed ID: 28662716
[TBL] [Abstract][Full Text] [Related]
35. Low HIV testing rates among US women who report anal sex and other HIV sexual risk behaviors, 2011-2015.
Evans ME; Tao G; Porter SE; Gray SC; Huang YA; Hoover KW
Am J Obstet Gynecol; 2018 Oct; 219(4):383.e1-383.e7. PubMed ID: 30144401
[TBL] [Abstract][Full Text] [Related]
36. Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.
Pleuhs B; Mistler CB; Quinn KG; Dickson-Gomez J; Walsh JL; Petroll AE; John SA
J Prim Care Community Health; 2022; 13():21501319211063999. PubMed ID: 35068243
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs.
Grimshaw C; Boyd L; Smith M; Estcourt CS; Metcalfe R
HIV Med; 2021 Nov; 22(10):965-970. PubMed ID: 34585494
[TBL] [Abstract][Full Text] [Related]
38. Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: Findings from an online survey.
Lim SH; Mburu G; Bourne A; Pang J; Wickersham JA; Wei CKT; Yee IA; Wang B; Cassolato M; Azwa I
PLoS One; 2017; 12(9):e0182838. PubMed ID: 28902857
[TBL] [Abstract][Full Text] [Related]
39. Human Immunodeficiency Virus/Sexually Transmitted Infection Counseling and Testing Services Received by Gay and Bisexual Men Using Preexposure Prophylaxis at Their Last PrEP Care Visit.
Parsons JT; John SA; Whitfield THF; Cienfuegos-Szalay J; Grov C
Sex Transm Dis; 2018 Dec; 45(12):798-802. PubMed ID: 30422969
[TBL] [Abstract][Full Text] [Related]
40. Characterizing Interest in and Uptake of Preexposure Prophylaxis for HIV Prevention Among Men in a US State Correctional System.
Ma EC; Rogers BG; Chan PA; Toma E; Almonte A; Napoleon S; Galipeau D; Ahluwalia JS; Murphy M
Sex Transm Dis; 2024 Mar; 51(3):162-170. PubMed ID: 38412463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
